Bonesupport Holding

BONEX · Nasdaq Stockholm · SEK

222,60 krVariation par rapport à la clôture précédente: −1,50 %Variation absolue: −3,40 kr

Clôture · 2 octobre 2026

Profil de la société

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Description disponible en anglais.

Informations sur la société

Secteur
Santé
Industrie
Medical Instruments & Supplies
Pays
Suède
Siège
Scheelevägen 19, 223 70, Lund
Salariés
171
Cotation
BONEX · Nasdaq Stockholm
Devise
SEK
ISIN
SE0009858152